Roux-en-Y Gastric Bypass Improves Hypertension, Hyperlipidemia and Type 2 Diabetes
Roux-en-Y Stomach Bypass Improves Blood Pressure, Blood Fats and Type 2 Diabetes
| Bariatric Surgery information Roux-en-Y Gastric Bypass Improves Hypertension, Hyperlipidemia and Type 2 Diabetes |
Roux-en-Y Stomach Bypass Improves Blood Pressure, Blood Fats and Type 2 Diabetes |
|
Weight Loss Surgery Information - Bariatric Research Studies |
Roux-en-Y Gastric Bypass Significantly Improves
Hypertension, Hyperlipidemia and
|
Method
A retrospective chart review was conducted of 138 patients who underwent Roux-en-Y gastric bypass between 1997 and 2000. Pre-surgical BMI, cholesterol, blood pressure, creatinine, number of antidepressant/ glycemic drugs, and hemoglobin were recorded. Post-surgical follow-up was reviewed to examine changes.
Results
Statistically significant changes were found in BMI, hypertension, cholesterol and glycemic control. Surgery was found to reduce creatinine from a pre-surgery average of 1.14 to 1.01. Patients with early post-operative complications (defined as length of stay > 6 days or re-hospitalization within 1 month following surgery) had an average BMI of 57.58 vs a BMI of 49.9 in those who did not experience any complications. There was a statistically significant decrease in the rate of anti-depressant use following surgery. 49 patients were on antidepressants before surgery vs 38 following surgery.
Conclusion
Roux-en-Y gastric bypass significantly improves hypertension, hyperlipidemia and type II diabetes, and may also improve kidney function. Patients with higher pre-surgical BMIs are at greater risk for post-surgical complications. Postoperative antidepressant use appears to decrease.
Source:
Holzwarth R, Huber D, Majkrzak A, Tareen B. University of North Dakota
School of Medicine and Health Sciences, Grand Forks, ND, USA. 2002